FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136454416> ?p ?o ?g. }

• W3136454416 abstract "Ligelizumab is a humanised IgG1 anti-IgE antibody that binds IgE with higher affinity than omalizumab. Ligelizumab had greater efficacy than omalizumab on inhaled and skin allergen provocation responses in mild allergic asthma. This multi-centre, randomised, double-blind study was designed to test ligelizumab in severe asthma patients not adequately controlled with high-dose inhaled corticoids plus long-acting β2-agonist.Patients received 16 weeks ligelizumab (240 mg q2w), omalizumab or placebo subcutaneously, and ACQ-7 was measured as primary outcome at Week 16. In addition, the study generated dose-ranging data of ligelizumab and safety data.A total of 471 patients, age 47.4 ± 13.36 years, were included in the study. Treatment with ligelizumab did not significantly improve asthma control (ACQ-7) and exacerbation rates compared to omalizumab and placebo. Therefore, primary and secondary objectives of the study were not met. The compound was well tolerated, and the safety profile showed no new safety findings. Pharmacokinetic data demonstrated faster clearance and lower serum concentrations of ligelizumab than historical omalizumab data, and exploratory in vitro data showed differential IgE blocking properties relative to FcεRI and FcεRII/CD23 between the two compounds.Ligelizumab failed to demonstrate superiority over placebo or omalizumab. Although ligelizumab is more potent than omalizumab at inhibiting IgE binding to the high-affinity FcεRI, there is differential IgE blocking properties relative to FcεRI and FcεRII/CD23 between the two compounds. Therefore, the data suggest that different anti-IgE antibodies might be selectively efficacious for different IgE-mediated diseases." @default.
• W3136454416 created "2021-03-29" @default.
• W3136454416 creator A5005604593 @default.
• W3136454416 creator A5007454309 @default.
• W3136454416 creator A5008457786 @default.
• W3136454416 creator A5010870367 @default.
• W3136454416 creator A5028028709 @default.
• W3136454416 creator A5041873031 @default.
• W3136454416 creator A5072269526 @default.
• W3136454416 creator A5074618247 @default.
• W3136454416 creator A5081773853 @default.
• W3136454416 creator A5085680989 @default.
• W3136454416 creator A5090158725 @default.
• W3136454416 date "2021-01-01" @default.
• W3136454416 modified "2023-10-02" @default.
• W3136454416 title "Ligelizumab treatment for severe asthma: learnings from the clinical development programme" @default.
• W3136454416 cites W1501757022 @default.
• W3136454416 cites W1966718625 @default.
• W3136454416 cites W1967215794 @default.
• W3136454416 cites W1971281271 @default.
• W3136454416 cites W1982386486 @default.
• W3136454416 cites W2004145744 @default.
• W3136454416 cites W2010416354 @default.
• W3136454416 cites W2025635164 @default.
• W3136454416 cites W2029587541 @default.
• W3136454416 cites W2062574496 @default.
• W3136454416 cites W2084213720 @default.
• W3136454416 cites W2102629488 @default.
• W3136454416 cites W2110052844 @default.
• W3136454416 cites W2111609315 @default.
• W3136454416 cites W2116150353 @default.
• W3136454416 cites W2123257822 @default.
• W3136454416 cites W2136060598 @default.
• W3136454416 cites W2164367822 @default.
• W3136454416 cites W2164548578 @default.
• W3136454416 cites W2217291519 @default.
• W3136454416 cites W2308777632 @default.
• W3136454416 cites W2319946384 @default.
• W3136454416 cites W2346668818 @default.
• W3136454416 cites W2416377389 @default.
• W3136454416 cites W2528141940 @default.
• W3136454416 cites W2601675613 @default.
• W3136454416 cites W2609560535 @default.
• W3136454416 cites W2775849530 @default.
• W3136454416 cites W2912559110 @default.
• W3136454416 cites W2978592627 @default.
• W3136454416 cites W2999840425 @default.
• W3136454416 doi "https://doi.org/10.1002/cti2.1255" @default.
• W3136454416 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7958305" @default.
• W3136454416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33747510" @default.
• W3136454416 hasPublicationYear "2021" @default.
• W3136454416 type Work @default.
• W3136454416 sameAs 3136454416 @default.
• W3136454416 citedByCount "19" @default.
• W3136454416 countsByYear W31364544162021 @default.
• W3136454416 countsByYear W31364544162022 @default.
• W3136454416 countsByYear W31364544162023 @default.
• W3136454416 crossrefType "journal-article" @default.
• W3136454416 hasAuthorship W3136454416A5005604593 @default.
• W3136454416 hasAuthorship W3136454416A5007454309 @default.
• W3136454416 hasAuthorship W3136454416A5008457786 @default.
• W3136454416 hasAuthorship W3136454416A5010870367 @default.
• W3136454416 hasAuthorship W3136454416A5028028709 @default.
• W3136454416 hasAuthorship W3136454416A5041873031 @default.
• W3136454416 hasAuthorship W3136454416A5072269526 @default.
• W3136454416 hasAuthorship W3136454416A5074618247 @default.
• W3136454416 hasAuthorship W3136454416A5081773853 @default.
• W3136454416 hasAuthorship W3136454416A5085680989 @default.
• W3136454416 hasAuthorship W3136454416A5090158725 @default.
• W3136454416 hasBestOaLocation W31364544162 @default.
• W3136454416 hasConcept C110586980 @default.
• W3136454416 hasConcept C126322002 @default.
• W3136454416 hasConcept C141105273 @default.
• W3136454416 hasConcept C142724271 @default.
• W3136454416 hasConcept C159654299 @default.
• W3136454416 hasConcept C203014093 @default.
• W3136454416 hasConcept C204787440 @default.
• W3136454416 hasConcept C2426938 @default.
• W3136454416 hasConcept C27081682 @default.
• W3136454416 hasConcept C2776042228 @default.
• W3136454416 hasConcept C2777014857 @default.
• W3136454416 hasConcept C2778564945 @default.
• W3136454416 hasConcept C34814297 @default.
• W3136454416 hasConcept C71924100 @default.
• W3136454416 hasConcept C98274493 @default.
• W3136454416 hasConceptScore W3136454416C110586980 @default.
• W3136454416 hasConceptScore W3136454416C126322002 @default.
• W3136454416 hasConceptScore W3136454416C141105273 @default.
• W3136454416 hasConceptScore W3136454416C142724271 @default.
• W3136454416 hasConceptScore W3136454416C159654299 @default.
• W3136454416 hasConceptScore W3136454416C203014093 @default.
• W3136454416 hasConceptScore W3136454416C204787440 @default.
• W3136454416 hasConceptScore W3136454416C2426938 @default.
• W3136454416 hasConceptScore W3136454416C27081682 @default.
• W3136454416 hasConceptScore W3136454416C2776042228 @default.
• W3136454416 hasConceptScore W3136454416C2777014857 @default.
• W3136454416 hasConceptScore W3136454416C2778564945 @default.
• W3136454416 hasConceptScore W3136454416C34814297 @default.
• W3136454416 hasConceptScore W3136454416C71924100 @default.
• W3136454416 hasConceptScore W3136454416C98274493 @default.

• next